329 related articles for article (PubMed ID: 19959616)
1. Sweetening the pot: adding glycosylation to the biomarker discovery equation.
Drake PM; Cho W; Li B; Prakobphol A; Johansen E; Anderson NL; Regnier FE; Gibson BW; Fisher SJ
Clin Chem; 2010 Feb; 56(2):223-36. PubMed ID: 19959616
[TBL] [Abstract][Full Text] [Related]
2. Cancer biomarker discovery: lectin-based strategies targeting glycoproteins.
Clark D; Mao L
Dis Markers; 2012; 33(1):1-10. PubMed ID: 22710864
[TBL] [Abstract][Full Text] [Related]
3. The sweet and sour of serological glycoprotein tumor biomarker quantification.
Kuzmanov U; Kosanam H; Diamandis EP
BMC Med; 2013 Feb; 11():31. PubMed ID: 23390961
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein analysis using protein microarrays and mass spectrometry.
Patwa T; Li C; Simeone DM; Lubman DM
Mass Spectrom Rev; 2010; 29(5):830-44. PubMed ID: 20077480
[TBL] [Abstract][Full Text] [Related]
5. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.
Narimatsu H; Sawaki H; Kuno A; Kaji H; Ito H; Ikehara Y
FEBS J; 2010 Jan; 277(1):95-105. PubMed ID: 19919546
[TBL] [Abstract][Full Text] [Related]
6. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification.
Makawita S; Diamandis EP
Clin Chem; 2010 Feb; 56(2):212-22. PubMed ID: 20007861
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis.
Abbott KL; Lim JM; Wells L; Benigno BB; McDonald JF; Pierce M
Proteomics; 2010 Feb; 10(3):470-81. PubMed ID: 19953551
[TBL] [Abstract][Full Text] [Related]
8. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
9. A multiplex lectin-channel monitoring method for human serum glycoproteins by quantitative mass spectrometry.
Ahn YH; Ji ES; Shin PM; Kim KH; Kim YS; Ko JH; Yoo JS
Analyst; 2012 Feb; 137(3):691-703. PubMed ID: 22158852
[TBL] [Abstract][Full Text] [Related]
10. One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature.
Dela Rosa MA; Chen WC; Chen YJ; Obena RP; Chang CH; Capangpangan RY; Su TH; Chen CL; Chen PJ; Chen YJ
Anal Chem; 2017 Apr; 89(7):3973-3980. PubMed ID: 28323416
[TBL] [Abstract][Full Text] [Related]
11. A lectin-coupled, multiple reaction monitoring based quantitative analysis of human plasma glycoproteins by mass spectrometry.
Ahn YH; Shin PM; Ji ES; Kim H; Yoo JS
Anal Bioanal Chem; 2012 Feb; 402(6):2101-12. PubMed ID: 22290386
[TBL] [Abstract][Full Text] [Related]
12. Enrichment and identification of glycoproteins in human saliva using lectin magnetic bead arrays.
Caragata M; Shah AK; Schulz BL; Hill MM; Punyadeera C
Anal Biochem; 2016 Mar; 497():76-82. PubMed ID: 26743719
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of aberrant protein glycosylation in liver cancer plasma by AAL-enrichment and MRM mass spectrometry.
Ahn YH; Shin PM; Kim YS; Oh NR; Ji ES; Kim KH; Lee YJ; Kim SH; Yoo JS
Analyst; 2013 Nov; 138(21):6454-62. PubMed ID: 24027776
[TBL] [Abstract][Full Text] [Related]
15. High-throughput lectin magnetic bead array-coupled tandem mass spectrometry for glycoprotein biomarker discovery.
Choi E; Loo D; Dennis JW; O'Leary CA; Hill MM
Electrophoresis; 2011 Dec; 32(24):3564-75. PubMed ID: 22180208
[TBL] [Abstract][Full Text] [Related]
16. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis.
Zhao J; Qiu W; Simeone DM; Lubman DM
J Proteome Res; 2007 Mar; 6(3):1126-38. PubMed ID: 17249709
[TBL] [Abstract][Full Text] [Related]
17. Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery.
Kim YS; Yoo HS; Ko JH
Protein Pept Lett; 2009; 16(5):499-507. PubMed ID: 19442229
[TBL] [Abstract][Full Text] [Related]
18. Cancer serum biomarkers based on aberrant post-translational modifications of glycoproteins: Clinical value and discovery strategies.
Silva ML
Biochim Biophys Acta; 2015 Dec; 1856(2):165-77. PubMed ID: 26232626
[TBL] [Abstract][Full Text] [Related]
19. Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.
Shah AK; Cao KA; Choi E; Chen D; Gautier B; Nancarrow D; Whiteman DC; Saunders NA; Barbour AP; Joshi V; Hill MM
Mol Cell Proteomics; 2015 Nov; 14(11):3023-39. PubMed ID: 26404905
[TBL] [Abstract][Full Text] [Related]
20. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.
Qiu Y; Patwa TH; Xu L; Shedden K; Misek DE; Tuck M; Jin G; Ruffin MT; Turgeon DK; Synal S; Bresalier R; Marcon N; Brenner DE; Lubman DM
J Proteome Res; 2008 Apr; 7(4):1693-703. PubMed ID: 18311904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
